Literature DB >> 11054767

Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction.

K S LaForge1, V Shick, R Spangler, D Proudnikov, V Yuferov, Y Lysov, A Mirzabekov, M J Kreek.   

Abstract

The human mu opioid receptor (MOR) plays a central role in mediating the effects of opioids, both endogenous and exogenous. Epidemiological studies have shown that addiction in general, and especially opiate addiction, has a heritable component. Clinical and laboratory studies suggest that the MOR gene may contribute to the heritable component of vulnerability to develop opiate addiction. Naturally occurring single nucleotide polymorphisms (SNPs) have been identified in the MOR gene by conventional methods. Two coding region SNPs, the A118G and C17T substitutions, occur at high allelic frequencies (10.5% and 6.6%, respectively, in our previous studies). These common SNPs cause amino acid changes in the receptor, and may have implications for differences in individual responses to opioids, as well as decreased or increased vulnerability to opiate addiction. The A118G substitution encodes a variant receptor with binding and signal transduction differences in response to beta-endorphin in cellular assays. Recent innovations in microchip technology offer new potential methods for SNP detection. We report here on the development of two separate approaches using custom oligonucleotide gelpad microarrays for detection of these two common SNPs of the MOR gene in human DNA samples. First, PCR-amplified genomic DNA samples were used to produce target sequences, which were labeled with fluorescent dye and hybridized to custom microchips. Oligonucleotides on these reusable microchips were designed to query nucleotide substitutions at positions 17 and 118 of the MOR gene. Thirty-six human DNA samples were assayed both on these custom microchips and by conventional automated gel sequencing, with highly concordant identification of both heterozygous and homozygous substitutions. A second approach was developed for the C17T SNP utilizing single nucleotide extension on custom microchips. These custom gelpad microchips have potential for the rapid and inexpensive detection of specific SNPs for genetic and genomic studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054767     DOI: 10.1002/1096-8628(20001009)96:5<604::aid-ajmg5>3.0.co;2-f

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  Minisequencing on oligonucleotide microarrays: comparison of immobilisation chemistries.

Authors:  K Lindroos; U Liljedahl; M Raitio; A C Syvänen
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  [Are polymorphisms in the mu-opioid receptor important for opioid therapy?].

Authors:  J Lötsch; R Freynhagen; G Geisslinger
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

3.  Toward a rational selection of treatment for addiction.

Authors:  Charles P O'Brien
Journal:  Curr Psychiatry Rep       Date:  2007-12       Impact factor: 5.285

4.  Novel microarray design strategy to study complex bacterial communities.

Authors:  Antoine Huyghe; Patrice Francois; Yvan Charbonnier; Manuela Tangomo-Bento; Eve-Julie Bonetti; Bruce J Paster; Ignacio Bolivar; Denise Baratti-Mayer; Didier Pittet; Jacques Schrenzel
Journal:  Appl Environ Microbiol       Date:  2008-01-18       Impact factor: 4.792

Review 5.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

6.  Optimization of oligonucleotide-based DNA microarrays.

Authors:  Angela Relógio; Christian Schwager; Alexandra Richter; Wilhelm Ansorge; Juan Valcárcel
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

7.  Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Ann Ho; Julie A Blendy; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

8.  Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.

Authors:  Cielito C Reyes-Gibby; Sanjay Shete; Trude Rakvåg; Samrat V Bhat; Frank Skorpen; Eduardo Bruera; Stein Kaasa; Pål Klepstad
Journal:  Pain       Date:  2006-12-06       Impact factor: 6.961

9.  The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity.

Authors:  Keith A Trujillo
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 10.  Molecular Basis of Opioid Action: From Structures to New Leads.

Authors:  Aashish Manglik
Journal:  Biol Psychiatry       Date:  2019-09-12       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.